NKTX - What's Going On With Cancer Drug-Developer Nkarta Stock? | Benzinga
Nkarta, Inc. (NASDAQ: NKTX) shares are blasting higher Monday, and the stock has gained more than 270% over the past month. Here's a look at what's going on.
What To Know:
According to documents filed with the SEC on Monday, Nkarta has updated its corporate presentation to reflect certain business and strategic updates.
Nkarta, Inc. is a ...